Replies to post #5745 on Arbutus Biopharma Corporation (ABUS)

[mick]

$ABUS ????? I LIKE DA READ

[mick]

$ABUS Arbutus Reports Second Quarter 2020 Financial Results and Provides Corporate Update

https://finance.yahoo.com/news/arbutus-reports-second-quarter-2020-113000595.html

GlobeNewswire
Arbutus Biopharma Corporation
,GlobeNewswire•August 7, 2020
Phase 1a/1b clinical trial for AB-729, a subcutaneously delivered RNAi agent, remains on track with results from additional cohorts expected in the second half of 2020

AB-836, an oral capsid inhibitor, remains on track for completion of IND enabling studies by the end of 2020

Actively screening multiple new molecular entities in recently initiated COVID-19 research program

Cash runway guidance extended into mid-2022

Conference Call and Webcast Scheduled Today at 8:45 AM ET